PCN30 A COST—UTILITY ANALYSIS MODEL FOR THE SECOND LINE TREATMENT OF METASTATIC RENAL CELL CARCINOMA IN MEXICO
May 1, 2007, 00:00
10.1016/S1098-3015(10)68940-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)68940-1/fulltext
Title :
PCN30 A COST—UTILITY ANALYSIS MODEL FOR THE SECOND LINE TREATMENT OF METASTATIC RENAL CELL CARCINOMA IN MEXICO
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)68940-1&doi=10.1016/S1098-3015(10)68940-1
First page :
Section Title :
Open access? :
No
Section Order :
122